Matthew Panuwat
About Matthew Panuwat
Matthew Panuwat, with a background in biology, physiology, and business, has held significant roles in business development within the biopharmaceutical sector.
Chief Business Officer Matthew Panuwat
Matthew Panuwat serves as the Chief Business Officer. His comprehensive experience in business development, corporate strategy, and financial management spans multiple sectors of the healthcare and biotechnology industries.
Matthew Panuwat's Education and Degrees
Matthew Panuwat holds a BS in biology from Santa Clara University. He furthered his education with an MS in physiology and biophysics from Georgetown University. Additionally, he earned an MBA from UCLA, equipping him with a robust foundation in both scientific and business disciplines.
Matthew Panuwat's Professional Background
Matthew Panuwat’s career includes significant roles in various prominent companies within the healthcare sector. Before his current role, he was the Senior Vice President of Business Development at Prothena, where he led partnership activities and established a global R&D collaboration with Celgene. He also served as the Head of Business Development at Medivation, overseeing M&A and licensing initiatives, including the acquisition of talazoparib from BioMarin. Prior to these roles, he worked in corporate development at Questcor until its merger with Mallinckrodt and spent nearly a decade with the Global Healthcare Investment Banking Group at Merrill Lynch.
Matthew Panuwat's Achievements in Business Development
In his capacity as Senior Vice President of Business Development at Prothena, Matthew Panuwat successfully led partnership activities and played a crucial role in establishing the company’s global research and development collaboration with Celgene. During his tenure at Medivation, he managed significant M&A and licensing activities, notably facilitating the acquisition of talazoparib from BioMarin, highlighting his strategic capabilities in corporate growth and development.